Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

Annals of Neurology

Volumn 32, Issue 6, 1992, Pages 758-766

  McFarland, Henry F ^a   Frank, Joseph A ^c   Albert, Paul S ^b   Smith, Mary E ^a   Martin, Roland ^a   Harris, Jonathan O ^a   Patronas, Nicholas ^c,d   Maloni, Heidi ^a   McFarlin, Dale E ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b National Institute of Neurological Diseases and Stroke   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT PLANNING;

ADULT; BRAIN; GADOLINIUM; HUMAN; MAGNETIC RESONANCE IMAGING; MIDDLE AGE; MULTIPLE SCLEROSIS; PROGNOSIS; RESEARCH DESIGN;

EID: 0026474514     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410320609     Document Type: Article

References (30)

1. Clinical trials in multiple sclerosis
2. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
3. Nuclear magnetic resonance imaging in multiple sclerosis
4. The initial diagnosis of multiple sclerosis: clinical impact of magnetic resonance imaging
5. Magnetic resonance imaging in multiple sclerosis: results of 32 cases
6. MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients
7. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study
8. MRI in the diagnosis of MS: a prospective study and comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
9. Multiple sclerosis: a serial study using MRI in relapsing patients
10. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients
11. Magnetic resonance imaging (MRI) in multiple sclerosis (MS); pathological correlation studies in eight cases
12. Multiple sclerosis: gadolinium enhancement in MR imaging
13. Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis
14. Duration and selectivity of blood‐brain barrier breakdown in chronic relapsing experimental allergic encephalomyclitis studied by gadolinium‐DTPA and protein markers
15. Breakdown of the blood‐brain barrier preceeds symptoms and other MRI signs of new lesions in multiple sclerosis
16. Gadolinium‐enhancing lesions on magnetic resonance imaging: neuropathological findings
17. Multiple sclerosis: serial study of gadolinium‐enhanced MR imaging
18. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis
19. Senal gadoliniumenhanced magnetic resonance imaging scans in patients with early, relapsing multiple sclerosis: implication for clinical trials and natural history
20. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines
21. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)
22. Problems of experimental trials of therapy in multiple sclerosis: report by the panal on the evaluation of experimental trials in multiple sclerosis
23. A test for synergism between two drugs
24. Statistical data analysis in the computer age
25. Major differences in the dynamics of primary and secondary progressive multiple sclerosis
26. Multiple sclerosis: diagnostic criteria and the role of contrast enhanced MRI
27. Serial enhanced MRI in early relapsing remitting and benign multiple sclerosis